Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Stock Market Today (LIVE): PPI Beats Fear, But Oil Risks Loom; Novo's OpenAI Deal Lifts Shares
09:33am, Tuesday, 14'th Apr 2026
Top insights from the latest market news from Tuesday, April 14, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
06:50pm, Thursday, 09'th Apr 2026
In the latest trading session, Moderna (MRNA) closed at $51.3, marking a -1.54% move from the previous day.
Meet the 2 Formerly Down-and-Out Stocks That Are Outperforming the S&P 500 This Year. Are They Still a Buy?
07:10am, Thursday, 09'th Apr 2026
In an uncertain market, investors have rushed to get in on these players seen as “safer” investments. They operate in the areas of healthcare and retail, selling treatments and products that are e
Bank of America flags international opportunities as key growth driver for Moderna
01:01pm, Wednesday, 08'th Apr 2026
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) is expected to highlight progress in international COVID-19 vaccine markets when it reports first quarter 2026 results, according to analysts at Bank of America. T
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Wednesday, 08'th Apr 2026
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Moderna eyes international markets as growth driver, says Bank of America
08:58am, Wednesday, 08'th Apr 2026
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) is expected to highlight progress in international COVID-19 vaccine markets when it reports first quarter 2026 results,...
You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500.
05:10am, Tuesday, 07'th Apr 2026
This company soared into the spotlight with its first product a few years ago. But in recent years, the company's earnings and stock price declined.
Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026
06:01pm, Monday, 06'th Apr 2026
CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on revaccination data for both mRNA-1010, i
Moderna: Speculative Buy For Aggressive Investors Betting On mRNA's Future
03:56am, Monday, 06'th Apr 2026
My previous recommendation of Moderna didn't work out so well, because COVID sales have declined over the last several years. Spikevax 2024 sales reached only $3.1B, and RSV sales were a major disappo
Moderna (MRNA) Stock Dips While Market Gains: Key Facts
06:50pm, Thursday, 02'nd Apr 2026
In the closing of the recent trading day, Moderna (MRNA) stood at $49.2, denoting a -1.66% move from the preceding trading day.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Tuesday, 31'st Mar 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next
10:45am, Monday, 30'th Mar 2026
The COVID-19 vaccine boom made fortunes almost overnight—and destroyed them just as fast.
MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI's 2026 Performance
08:15am, Sunday, 29'th Mar 2026
SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal footing, regardless of size.
Moderna (MRNA) Falls More Steeply Than Broader Market: What Investors Need to Know
06:51pm, Friday, 27'th Mar 2026
Moderna (MRNA) concluded the recent trading session at $49.56, signifying a -7.49% move from its prior day's close.
ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential?
10:16am, Friday, 27'th Mar 2026
IBRX and MRNA hinge on single-drug success, but pipeline depth, growth plans and risks set them apart in the race for biotech upside.
